STARTUP PROFILE

Nexstim

COUNTRY
Finland
FOUNDED
2000
CATEGORY
Neuromodulation
Developing navigated transcranial magnetic stimulation systems for non-invasive brain mapping and neuromodulation in clinical and research settings.
Visit website →
Neurofounders Insights
$   Funding   -
Public
MODALITY
TMS
FORM FACTOR
External device
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
Nexstim is a long-standing navigated TMS company, differentiated by image-guided targeting that improves stimulation precision for mapping and therapy. Its public-market presence and procedural maturity place it closer to incumbent neurostimulation infrastructure than startup experimentation.
Mentioned in Market Notes
MOST RECENT COVERAGE
#
2
Neuromodulation Pushes On
26 May – 9 June 2026

Nexstim was granted authorization for commercial distribution of its NBS System 6 in Australia. The system uses navigated transcranial magnetic stimulation for diagnostic brain mapping. The Australian clearance extends the company's geographic footprint.

Articles featuring
Nexstim
No items found.